You have 5 free articles left this month. Get your free Basic subscription now and gain instant access to more.

Serbia to get first doses of Merck's COVID-19 drug in Dec - health official

Author Radomir Ralev
Serbia to get first doses of Merck's COVID-19 drug in Dec - health official Photo: EBRD

BELGRADE (Serbia), November 24 (SeeNews) - Serbia expects to receive next month its first doses of Molnupiravir, the COVID-19 antiviral drug of US-based drugmaker Merck, the director of Serbia's Republic Fund of Health Insurance, Sanja Radojevic Skodric, said on Wednesday.

"We have ordered 50,000 doses of the drug but we do not have a limit and we can order more later," Skodric said in a video file posted on the YouTube channel of private broadcaster K1.

Serbia will be the first European country to receive Molnupiravir which can be used to treat adults with COVID-19 who do not require supplemental oxygen and who are at increased risk of developing severe symptoms, Skodric said.

"In January or February Serbia will also receive the first deliveries of the COVID-19 drug of Pfizer," she added.

Earlier this month, Serbia signed an agreement with Pfizer for the delivery of the company's experimental antiviral candidate Paxlovid for treatment of COVID-19.

Compare